Medicare Enrolled
Dr. Brock Harper, M.D.
Rheumatology · Cedar Park, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harper?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harper
Dr. Brock Harper is a rheumatology specialist in Cedar Park, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harper performed 17,259 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Harper received a total of $45,354 from 58 pharmaceutical and/or device companies across 1510 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harper is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 33% volume in TX
$45,354 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,259
Medicare services
Top 33% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
7,327 | $32 | $108 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
7,100 | $10 | $25 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,850 | $25 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $92 | $394 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
166 | $52 | $216 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $63 | $279 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
69 | $11 | $45 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
55 | $23 | $92 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
43 | $108 | $439 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $121 | $510 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
24 | $13 | $51 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
95.5% high complexity
0.9% medium
3.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,354
Total received (2018-2024)
Avg $6,479/year across 7 years
Top 10% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,510
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,824
2023
$4,399
2022
$3,301
2021
$3,758
2020
$8,208
2019
$10,044
2018
$10,820
Payments by company (2024)
Janssen Scientific Affairs, LLC
$1,249
Janssen Biotech, Inc.
$477
Novartis Pharmaceuticals Corporation
$459
UCB, Inc.
$440
ABBVIE INC.
$327
Amgen Inc.
$297
AstraZeneca Pharmaceuticals LP
$224
GENZYME CORPORATION
$222
Aurinia Pharma U.S., Inc.
$171
Johnson & Johnson Health Care Systems Inc.
$150
Fresenius Kabi USA, LLC
$140
Lilly USA, LLC
$132
PFIZER INC.
$106
E.R. Squibb & Sons, L.L.C.
$67
Octapharma USA, Inc.
$60
Organon Llc
$50
Abbott Laboratories
$48
Radius Health, Inc.
$41
ANI Pharmaceuticals, Inc.
$38
GlaxoSmithKline, LLC.
$35
SOBI, INC
$29
HOSPIRA, INC.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Biocon Biologics Inc
$15
Takeda Pharmaceuticals U.S.A., Inc.
$13
Top 3 companies account for 45.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$9,742
Janssen Biotech, Inc.
$5,601
Novartis Pharmaceuticals Corporation
$5,131
Amgen Inc.
$2,913
UCB, Inc.
$2,612
PFIZER INC.
$1,920
ABBVIE INC.
$1,819
GENZYME CORPORATION
$1,664
Janssen Scientific Affairs, LLC
$1,249
AbbVie, Inc.
$1,222
SANOFI-AVENTIS U.S. LLC
$1,152
GlaxoSmithKline, LLC.
$1,117
AbbVie Inc.
$914
E.R. Squibb & Sons, L.L.C.
$831
Horizon Therapeutics plc
$811
Celgene Corporation
$765
AstraZeneca Pharmaceuticals LP
$679
Mallinckrodt Hospital Products Inc.
$546
Horizon Pharma plc
$523
Genentech USA, Inc.
$468
Aurinia Pharma U.S., Inc.
$380
Octapharma USA, Inc.
$248
Boehringer Ingelheim Pharmaceuticals, Inc.
$247
Merck Sharp & Dohme Corporation
$233
Daiichi Sankyo Inc.
$213
Mallinckrodt LLC
$184
Antares Pharma, Inc.
$181
Mallinckrodt Enterprises LLC
$164
Johnson & Johnson Health Care Systems Inc.
$150
Sobi, Inc
$147
Fresenius Kabi USA, LLC
$140
Radius Health, Inc.
$140
Actelion Pharmaceuticals US, Inc.
$122
Takeda Pharmaceuticals U.S.A., Inc.
$112
Flexion Therapeutics, Inc.
$110
Grifols USA, LLC
$108
Abbott Laboratories
$92
Hikma Pharmaceuticals USA
$85
Alexion Pharmaceuticals, Inc.
$75
Ironwood Pharmaceuticals, Inc
$71
SOBI, INC
$52
Organon Llc
$50
Ultragenyx Pharmaceutical Inc.
$46
West-Ward Pharmaceuticals
$39
ANI Pharmaceuticals, Inc.
$38
MEDAC PHARMA, INC.
$38
Purdue Pharma L.P.
$25
Eisai Inc.
$23
CSL Behring
$20
Teva Pharmaceuticals USA, Inc.
$19
HOSPIRA, INC.
$17
Boston Scientific Corporation
$17
Biocon Biologics Inc
$15
Shionogi Inc
$15
Gilead Sciences, Inc.
$15
Ferring Pharmaceuticals Inc.
$14
Egalet US Inc
$14
Jazz Pharmaceuticals Inc.
$12
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · Dayvigo · EUFLEXXA · EVENITY · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · Gamunex-C · HADLIMA · HUMIRA · Hizentra · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · Otrexup · PANZYGA · PENNSAID · PROCLAIM · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · SUNOSI · SYMPROIC · SYNVISC-ONE · Symproic · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · Tavneos · Trintellix · Truxima · Tymlos · UPTRAVI · Uloric · Ultomiris · VIMOVO · VPRIV · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
28
County median income
$108,309
Nearest hospital to ZIP centroid (approximate)
CEDAR PARK REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harper is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harper experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Harper performed 7,327 abatacept infusion (orencia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Harper receive payments from pharmaceutical companies?
Yes. Dr. Harper received a total of $45,354 from 58 companies across 1,510 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harper's costs compare to other rheumatologists in Cedar Park?
Dr. Harper's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Cedar Park
Browse rheumatologists in Cedar Park ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology